Status
Conditions
Treatments
About
Patients with atrial fibrillation (AF) and heart failure with reduced left ventricular ejection fraction (HFrEF) are at particularly high cardiovascular risk. Rhythm-control by means of catheter-based pulmonary vein isolation (PVI) reduces all-cause mortality and rehospitalization for worsening heart failure in these patients. Considering the globally increasing use of the novel "pulsed-field ablation", it is necessary to determine whether this technique can be performed with the same safety and efficacy as the established cryoballoon ablation (CBA) in this critically ill patient population.
This research project aims to retrospectively compare, in a multicenter study, PVI using PFA and CBA in patients with AF and concomitant HFrEF based on pre-collected pseudonymized patient data through propensity score matching.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
500 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal